agilon health, inc. SEC 10-Q Report

agilon health, inc., a company specializing in providing healthcare services through capitation fees under contracts with various Medicare Advantage payors, has released its Form 10-Q report for the first quarter of 2025. The report outlines the company's financial and operational performance, highlighting key metrics and future outlooks.

Financial Highlights

Total Revenues: $1,532.8 million, a decrease of 4% from the first quarter of 2024 due to a decline in average membership and partnership exits.

Gross Profit: $50.7 million, a decrease of 32% from the first quarter of 2024, reflecting lower revenue and increased medical services expenses.

Income (loss) from operations: $(22.1) million, compared to $(7.2) million in the first quarter of 2024, indicating increased operational losses.

Net Income (loss): $12.1 million, compared to a net loss of $6.0 million in the first quarter of 2024, primarily due to gains from discontinued operations.

Net income (loss) per common share from continuing operations, basic and diluted: $0.00, compared to $0.01 in the first quarter of 2024, reflecting stable earnings per share from continuing operations.

Business Highlights

Revenue Segments: The company’s medical services revenue is primarily derived from capitation fees under contracts with various Medicare Advantage payors. These fees are based on a per-member, per-month (PMPM) model, which is adjusted according to CMS's risk adjustment payment methodology.

Geographical Performance: The company operates 33 wholly-owned risk-bearing entities (RBEs) across various geographies, which are responsible for entering into risk-bearing contracts with payors. The company has seen a decline in Medicare Advantage members by 6% as of March 31, 2025, due to market exits during 2024, partially offset by growth in existing geographies.

Sales Units: As of March 31, 2025, the company provided care to approximately 490,700 Medicare Advantage members and 114,100 CMS ACO Models beneficiaries, reflecting a decrease in membership compared to the previous year.

Future Outlook: The company expects to continue incurring operating losses and generating negative cash flows from operations due to ongoing investments in business expansion and additional general and administrative costs. However, it believes that its existing cash, cash equivalents, and marketable securities will be sufficient to meet its working capital and capital expenditure needs over the next 12 months.

SEC Filing: agilon health, inc. [ AGL ] - 10-Q - May. 06, 2025